- Home
- CRIS vs CFND Comparison
CRIS vs CFND Comparison
Compare CRIS & CFND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRIS | CFND |
|---|---|---|
| Founded | 2000 | N/A |
| Country | United States | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.6M | 20.4M |
| IPO Year | 2000 | 2024 |
Fundamental Metrics
Financial Performance| Metric | CRIS | CFND |
|---|---|---|
| Price | $0.99 | $3.36 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $17.00 | N/A |
| AVG Volume (30 Days) | ★ 117.7K | 96.0K |
| Earning Date | 05-07-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.57 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,898,000.00 | N/A |
| Revenue This Year | $27.10 | N/A |
| Revenue Next Year | $67.74 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 31.50 | N/A |
| 52 Week Low | $0.18 | $2.04 |
| 52 Week High | $6.74 | $8.64 |
Technical Indicators
Market Signals| Indicator | CRIS | CFND |
|---|---|---|
| Relative Strength Index (RSI) | 20.56 | 59.16 |
| Support Level | $0.95 | $3.18 |
| Resistance Level | $1.04 | $3.53 |
| Average True Range (ATR) | 0.10 | 0.18 |
| MACD | 0.05 | 0.03 |
| Stochastic Oscillator | 4.04 | 72.77 |
Price Performance
Historical ComparisonAbout CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About CFND C1 Fund Inc.
C1 Fund Inc is a non-diversified, closed-end management investment company. The Adviser provides day-to-day investment management services to the Company, which is classified as non-diversified under the Investment Company Act. The Company's investment objective is to maximize its portfolio's total return by principally investing in privately held equity and equity-linked securities of digital asset services and technology companies. Its investments in equity securities include common and preferred shares, securities convertible into common shares, warrants and rights to subscribe to or purchase common shares, and common shares carrying a warrant or right.